HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal triamcinolone acetonide in the treatment of macular retinal detachment associated with morning glory anomaly.

AbstractPURPOSE:
To report the successful treatment of a case of recurrent macular retinal detachment associated with morning glory anomaly using intravitreal triamcinolone acetonide.
METHODS:
A 53-year-old man with a history of bilateral morning glory anomaly and recurrent macular detachment of the left eye refractory to multiple surgical interventions, including 3 vitrectomies with endolaser photocoagulation, gas tamponade, and fibrin glue, underwent an intravitreal injection of 4 mg triamcinolone acetonide.
RESULTS:
A single treatment with intravitreal triamcinolone acetonide resulted in resolution of a macular retinal detachment and intraretinal fluid within 2 weeks.
CONCLUSION:
Treatment with intravitreal triamcinolone acetonide may be beneficial in cases of macular retinal detachment associated with morning glory anomaly.
AuthorsAnnie C Lee, Julia A Haller, Kenneth R Jaegers Sr, Brooks W McCuen 2nd
JournalRetinal cases & brief reports (Retin Cases Brief Rep) Vol. 3 Issue 4 Pg. 333-5 ( 2009) ISSN: 1935-1089 [Print] United States
PMID25389840 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: